James Bligh - 18 Nov 2024 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDT	Stock Option (Right to Buy)	Award	$173,691	+1,890,000		$0.0919	1,890,000	18 Nov 2024	Common Stock	1,890,000	$0.0919	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Represents Options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan.
F2	The Options vest as follows: (i) 50% on the grant date and (ii) 50% in equal annual installments on the first three anniversaries of the grant date.